Cancer

A new study finds that infections are responsible for roughly one in eight cancer cases globally. The finding highlights the role of viruses and bacteria, such as those causing cervical and liver cancers, in the global cancer burden, and is drawing attention to vaccination and treatment as prevention tools.

Roughly one in eight cancer cases worldwide is traced directly to infectious pathogens, chiefly human papillomavirus, Helicobacter pylori, and hepatitis B and C viruses. Health commentators stress that many of these cancers are preventable or treatable through vaccination, screening, and targeted antimicrobial treatment, making infection control one of the most cost-effective cancer prevention strategies available globally.

A growing list of people associated with October 4 in any year now includes Henrietta Lacks, the Black woman whose cancer cells were taken without her consent in 1951 and became foundational to modern medical research. The listing places her alongside other notable figures tied to the date, and is being shared in discussions of Black history and representation in film and television.

An essay at Breakthrough Journal argues that the public is routinely told that a long list of ordinary things supposedly cause cancer, reflecting ongoing frustration with shifting and often contradictory health warnings. Readers are debating how much of cancer-risk research holds up, and why scare headlines about everyday products keep appearing despite weak or inconsistent evidence.

South Africa's Proteas faced Australia in the second One Day International of their series, played on the annual Pink Day fixture that raises awareness and funds for breast cancer causes. Fans are watching the highlights and reacting to how the match unfolded at a packed ground dressed in pink.

Ukraine has issued medical cannabis-based medication to a cancer patient for the first time, a milestone in the country's move to legalise cannabinoid therapy. The change follows Ukraine's 2024 decision to permit medical cannabis, and the first prescription marks the practical start of access for patients undergoing cancer treatment. It is being discussed as a significant step for Ukrainian healthcare amid the war.

The first day of Breast Cancer Awareness Month has doctors across the United States urging women to prioritise early screening. A Denver physician told CBS News that early detection is key to improving outcomes, while a Colorado Springs imaging specialist emphasised the importance of regular mammograms, as health providers use the annual awareness month to encourage appointments.

A study from the University of Arizona indicates that sex chromosomes play a direct role in how the body handles cancer, cardiovascular health and lifespan. The findings suggest biological differences between male and female cells go beyond hormones, potentially reshaping how researchers approach disease risk and treatment. It is drawing attention in health media as part of a broader push to understand sex-based differences in medicine.

German TV presenter Sarah Kuttner has cancelled all her upcoming appearances. According to German media reports, the cancellations follow a visit to her gynaecologist for cancer screening, with the presenter describing it as bad news from her doctor. Multiple outlets including Bild, T-Online and Focus Online are covering the story, though details about her condition have not been made public.

Readers across India and beyond are checking their daily horoscopes for October 2, 2026, with astrological predictions dominating lifestyle coverage. The Times of India published sign-by-sign forecasts, including Virgo's 'spiritual calm' and Cancer's money-focused reading, alongside a Shani-based Saturn warning for Cancer. Vogue India offered a Scorpio forecast, while YourTango highlighted five zodiac signs set for especially beautiful days.

Neko Health, the preventive health startup co-founded by Spotify chief Daniel Ek, has expanded to the United States. The company offers full-body scans designed to detect early signs of cardiovascular disease, cancer and other conditions. Its US arrival marks a step in bringing preventive scanning services to the American market, following its earlier launch in Europe.

A new discussion questions whether a truncated ALK transcript found in solid tumours is a genuinely useful biomarker for cancer detection and treatment, or an overhyped finding of unclear biological significance. ALK alterations are already important in lung cancer therapy, so debate centres on whether this variant can guide clinical decisions or remains poorly understood.

New findings presented ahead of the EADV 2026 congress link climate change to shifts in skin disease patterns worldwide. Rising temperatures, increased UV exposure, and changing humidity are being associated with growing rates of skin cancer, eczema flare-ups, and the spread of tropical dermatological conditions to new regions. Dermatologists say the findings add to mounting evidence that global warming is affecting human health directly, and are calling for greater awareness and preparedness among skin health services.

Iovance Biotherapeutics, the biotechnology company behind the cell therapy Amtagvi, is seeing its IOVA shares tracked closely by investors on finance platforms. Traders are following the stock price, quotes and recent news flow as the company works to commercialise its tumour-infiltrating lymphocyte therapies. No specific earnings announcement or clinical update is confirmed, leaving the exact catalyst for interest unclear.

Bayer is facing a new trial in Missouri over its Roundup weedkiller while a proposed $7.25 billion settlement to resolve thousands of claims that the product causes cancer awaits a judge's ruling. The case is part of long-running litigation over glyphosate, with the outcome of the settlement review likely to shape how remaining claims proceed.

Sylvester Comprehensive Cancer Center is raising the question of who is helping determine how artificial intelligence is implemented in clinical trial operations. The item, highlighted by Oncodaily, points to an ongoing discussion in the oncology research community about the role clinicians, coordinators and sponsors play in adopting AI tools for running trials.

A report highlights the mental health toll that breast cancer takes on patients, beyond the physical disease. Coverage points to anxiety, depression and emotional strain that often accompany diagnosis and treatment, underscoring calls for psychological support to be treated as part of standard cancer care. Discussions are focusing on how patients, families and health services address these often overlooked effects.

New research indicates that the loss of a single gene can allow melanoma to evade targeted cancer therapies. The finding helps explain why patients often relapse after initially responding to drugs designed to attack specific melanoma mutations. Scientists say understanding this resistance mechanism could guide new treatment combinations and improve outcomes for skin cancer patients.

The US National Cancer Institute has opened a search for a Deputy Director of its Division of Cancer Biology. The role would involve helping lead the division that oversees fundamental research into how cancer develops. The announcement is circulating among oncology researchers and cancer news outlets, with details on qualifications and applications available through the institute.